Brenntag has announced the acquisition of mcePharma. The acquisition and additional investments in the site of mcePharma will "strengthen" Brenntag’s capabilities across the pharma and biopharma value chain.
Medicines Discovery Catapult (MDC) and the Francis Crick Institute have announced a new strategic partnership to support the delivery of KQ Labs, a national accelerator for data-driven health science start-ups.
OneChain Immunotherapeutics (OCI), a clinical-stage biotech company focused on the development of CAR-T therapies for the treatment of oncologic diseases, has announced the appointment of Barbara Krebs-Pohl as the new chair of the Board of Directors.
Enterome SA presented new positive data from its ongoing Phase 1/2 “AUDREY” trial of its OncoMimics immunotherapy, EO4010, at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.
iOnctura, a clinical-stage biopharmaceutical company, has announced the appointments of Steven Sciuto as chief financial officer (CFO) and Michelle Tsai PharmD as chief operating officer (COO).
Clinigen, the global specialty pharmaceutical services group, has highlighted a key collaborative milestone with Shionogi, an impact-driven pharmaceutical company, marking the launch of their new strategic relationship.
PSB Industries, a specialist in the design and fabrication of systems for dehydrating and purifying gasses and liquids, is highlighting its Siloxane Removal packaged skid, an advanced gas purification system.
pharma& has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a variation to the Marketing Authorisation for Pegasys (peginterferon alfa-2a).
Nuclera, the biotechnology company accelerating protein expression and optimisation through its benchtop eProtein Discovery System, has announced a collaboration with Cytiva.
